Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MORF | Common Stock | Options Exercise | $43.2K | +10K | +8.61% | $4.32* | 126K | Feb 14, 2023 | Direct | |
transaction | MORF | Common Stock | Sale | -$401K | -10K | -7.92% | $40.09 | 116K | Feb 14, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MORF | Stock Option (right to buy Common Stock) | Options Exercise | $0 | -10K | -6.75% | $0.00 | 138K | Feb 14, 2023 | Common Stock | 10K | $4.32 | Direct | F2 |
Id | Content |
---|---|
F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
F2 | The option vests as to 2.0833% of the total shares monthly, beginning January 14, 2019, with 100% of the total shares vested and exercisable on December 14, 2022, subject to the reporting person's provision of service to the issuer on each vesting date. |